{"id":"https://openalex.org/W2241237448","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.2032","title":"Phase I/randomized phase II trial of either dasatinib or placebo combined with standard chemoradiotherapy for newly diagnosed glioblastoma multiforme (GBM): Final results of phase I study.","display_name":"Phase I/randomized phase II trial of either dasatinib or placebo combined with standard chemoradiotherapy for newly diagnosed glioblastoma multiforme (GBM): Final results of phase I study.","publication_year":2012,"publication_date":"2012-05-20","ids":{"openalex":"https://openalex.org/W2241237448","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.2032","mag":"2241237448"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2012.30.15_suppl.2032","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.2032","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2012.30.15_suppl.2032","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071466700","display_name":"Nadia N. Laack","orcid":"https://orcid.org/0000-0002-4385-6349","observed_orcids":["https://orcid.org/0000-0002-4385-6349"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nadia N. Laack","raw_affiliation_strings":["Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017494786","display_name":"Evanthia Galanis","orcid":"https://orcid.org/0000-0001-8014-786X","observed_orcids":["https://orcid.org/0000-0001-8014-786X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Evanthia Galanis","raw_affiliation_strings":["Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081908411","display_name":"Clinton Leinweber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210144818","display_name":"Radiation Oncology Associates","ror":"https://ror.org/03dsbzv79","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210144818"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Clinton Leinweber","raw_affiliation_strings":["Allentown Radiation Oncology Associates, Allentown, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allentown Radiation Oncology Associates, Allentown, PA","institution_ids":["https://openalex.org/I4210144818"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034104319","display_name":"Jan C. Buckner","orcid":"https://orcid.org/0000-0002-8688-266X","observed_orcids":["https://orcid.org/0000-0002-8688-266X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jan C. Buckner","raw_affiliation_strings":["Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069689120","display_name":"Caterina Giannini","orcid":"https://orcid.org/0000-0003-2757-6782","observed_orcids":["https://orcid.org/0000-0003-2757-6782"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Caterina Giannini","raw_affiliation_strings":["Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110135027","display_name":"Francois J. Geoffroy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136917","display_name":"Illinois CancerCare","ror":"https://ror.org/03vfgta75","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210136917"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Francois J. Geoffroy","raw_affiliation_strings":["Illinois Cancer Care, Peoria, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Illinois Cancer Care, Peoria, IL","institution_ids":["https://openalex.org/I4210136917"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023657472","display_name":"Kurt A. Jaeckle","orcid":"https://orcid.org/0000-0002-7827-463X","observed_orcids":["https://orcid.org/0000-0002-7827-463X"]},"institutions":[{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kurt A. Jaeckle","raw_affiliation_strings":["Mayo Clinic, Jacksonville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Jacksonville, FL","institution_ids":["https://openalex.org/I4210146710"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015247761","display_name":"Jann Nagina Sarkaria","orcid":"https://orcid.org/0000-0001-7489-4885","observed_orcids":["https://orcid.org/0000-0001-7489-4885"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jann Nagina Sarkaria","raw_affiliation_strings":["Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"30","issue":"15_suppl","first_page":"2032","last_page":"2032"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":0.9660000205039978},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.8859999775886536},{"id":"https://openalex.org/keywords/chemoradiotherapy","display_name":"chemoradiotherapy","score":0.9869999885559082},{"id":"https://openalex.org/keywords/src-inhibitors","display_name":"Src kinase inhibitor","score":0.7680000066757202},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7360000014305115},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9819999933242798},{"id":"https://openalex.org/keywords/lymphopenia","display_name":"lymphopenia","score":0.7379999756813049},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.796999990940094},{"id":"https://openalex.org/keywords/newly-diagnosed-glioblastoma","display_name":"newly diagnosed glioblastoma","score":0.8050000071525574},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5460000038146973},{"id":"https://openalex.org/keywords/oral-kinase-inhibitor","display_name":"oral kinase inhibitor","score":0.5929999947547913},{"id":"https://openalex.org/keywords/pancytopenia","display_name":"pancytopenia","score":0.6830000281333923},{"id":"https://openalex.org/keywords/anemia","display_name":"anemia","score":0.414000004529953},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.906000018119812}],"concepts":[{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.9739099740982056},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8894742131233215},{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.7842260599136353},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5584161281585693},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5048061609268188},{"id":"https://openalex.org/C2778424827","wikidata":"https://www.wikidata.org/wiki/Q5090613","display_name":"Chemoradiotherapy","level":3,"score":0.4915383756160736},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.4877053201198578},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4829346835613251},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.4809838533401489},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.43645408749580383},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.35997387766838074},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3582114279270172},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.32639265060424805},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.2960318326950073},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.11967107653617859},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.10881349444389343},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2012.30.15_suppl.2032","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.2032","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2012.30.15_suppl.2032","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.7200000286102295,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2118311655","https://openalex.org/W2042969729","https://openalex.org/W2990424668","https://openalex.org/W2078219238","https://openalex.org/W2121585125","https://openalex.org/W2123133319","https://openalex.org/W2883045718","https://openalex.org/W2279599902","https://openalex.org/W2770147923","https://openalex.org/W2081797247"],"abstract_inverted_index":{"2032":[0],"Background:":[1],"Dasatinib":[2,92],"is":[3,29,58,181,341,354],"a":[4,30],"potent":[5],"oral":[6],"ATP":[7],"competitive":[8],"multi-targeted":[9],"kinase":[10,18],"inhibitor":[11],"of":[12,15,39,61,74,89,104,113,137,148,159,162,215,253,283,299],"multiple":[13],"members":[14],"the":[16,37,59,72,85,90,101,126,135,157,213,266,273,359],"Src":[17],"family,":[19],"known":[20],"to":[21,70,134,208,212,257,292],"be":[22,209,258],"involved":[23],"in":[24,46,76,203,226,243,281,287,296,313,318,324,330,336,358],"gliomagenesis":[25],"and":[26,43,57,80,83,110,152,235,294,306,321,334],"invasion.":[27],"N0877":[28],"phase":[31,33,51,86,363],"I/randomized":[32],"II":[34,87,364],"trial":[35],"evaluating":[36],"combination":[38,77,331],"dasatinib,":[40,165],"radiation":[41],"(RT)":[42],"temozolomide":[44],"(TMZ)":[45],"newly":[47,337],"diagnosed":[48,338],"GBM.":[49],"The":[50],"I":[52,179],"portion":[53],"has":[54],"been":[55],"completed":[56],"focus":[60],"this":[62],"report.":[63],"Methods:":[64],"A":[65,117],"cohorts-of-3":[66],"design":[67],"was":[68,93,224,241,255,310,345],"used":[69,357],"assess":[71],"safety":[73],"dasatinib":[75,149,169,254,329],"with":[78,100,183,272,332,348],"RT":[79,105,335],"concomitant":[81],"TMZ,":[82],"establish":[84],"dose":[88,107,112,188,193,198,204,230,247,353],"combination.":[91],"given":[94],"orally":[95],"for":[96,132,328],"42":[97,120],"days,":[98],"beginning":[99],"first":[102,111],"day":[103,121,146,172],"(total":[106],"60":[108],"Gy)":[109],"TMZ":[114,153,163,333],"(75":[115],"mg/m2/d).":[116],"24":[118],"-":[119],"rest":[122],"(cycle":[123],"2)":[124],"followed":[125],"RT/TMZ/dasatinib.":[127],"Patients":[128,140],"(pts)":[129],"were":[130,270],"observed":[131,225,242],"DLT":[133,220,237],"end":[136],"cycle":[138],"2.":[139,325],"then":[141],"received":[142],"6":[143,160],"cycles":[144,161],"(28":[145,171],"cycles)":[147,173],"(once":[150],"daily)":[151],"(days":[154],"1-5).":[155],"At":[156],"completion":[158],"+":[164],"pts":[166],"stay":[167],"on":[168],"only":[170],"until":[174],"progressive":[175,316],"disease.":[176],"Results:":[177],"Phase":[178],"component":[180],"complete":[182],"13":[184],"patients":[185,300,340],"(3":[186],"at":[187,192,197,229,246],"level":[189,194,199,205,231,248],"0,":[190],"3":[191,239,280],"0-A,":[195],"7":[196],"1).":[200],"One":[201,219],"patient":[202,228,245],"1":[206,227,244,249,319],"had":[207],"replaced":[210],"due":[211],"development":[214],"unrelated":[216],"medical":[217],"issues.":[218],"(grade":[221,238,279],"4":[222,286],"pancytopenia)":[223],"0":[232],"(50mg":[233],"bid)":[234],"one":[236],"rash)":[240],"(150mg":[250],"qd).":[251],"MTD":[252,327],"determined":[256],"150mg":[259,342],"daily.":[260,343],"Most":[261],"common":[262,275],"adverse":[263],"events":[264],"throughout":[265],"entire":[267],"study":[268],"period":[269],"hematologic":[271,347],"most":[274],"toxicity":[276],"being":[277,356],"lymphopenia":[278],"69%":[282],"patients,":[284,315],"grade":[285],"8%).":[288],"Other":[289],"toxicities":[290],"attributed":[291],"treatment":[293],"occurring":[295],">":[297],"10%":[298],"included":[301],"anemia":[302],"(31%),":[303],"neutropenia":[304],"(15%),":[305],"fatigue(15%).":[307],"Best":[308],"response":[309],"stable":[311],"disease":[312,317],"10":[314],"patient,":[320],"not":[322],"evaluable":[323],"Conclusions:":[326],"GBM":[339],"Toxicity":[344],"primarily":[346],"minimal":[349],"non-hematologic":[350],"events.":[351],"This":[352],"currently":[355],"ongoing":[360],"placebo-controlled,":[361],"randomized":[362],"trial.":[365]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2025-10-10T00:00:00"}